Investors in a London-listed medical technology firm are continuing their campaign to oust the company’s top brass as its share price languishes. Read this story
Investors in a London-listed medical technology firm are continuing their campaign to oust the company’s top brass as its share price languishes. Read this story
More from @cityam | Business Technology